Jan 5 (Reuters) - Pharnext SA PHARN.PA :
* ANNOUNCES IT IS IN DISCUSSIONS WITH INVESTMENT RESEARCH
FIRM
EDISON TO UPDATE ITS RESEARCH NOTE AND VALUATION OF COMPANY'S
ASSETS
* PHARNEXT CURRENTLY FAVORS AN AGREEMENT WITH A PLAYER IN
PHARMACEUTICAL INDUSTRY.
* HAS UNDERTAKEN TO CARRY OUT AN INDEPENDENT FINANCIAL
ANALYSIS BY
A RECOGNIZED INVESTMENT RESEARCH FIRM TO DETERMINE INTRINSIC
VALUE AND TARGET SHARE PRICE
* EDISON IS PLANNING TO PUBLISH AN UPDATED VERSION OF
FINANCIAL
ANALYSIS NOTE BY END OF Q1 2023
Source text for Eikon: ID:nACT77890
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))